[HTML][HTML] Neutralization of SARS-CoV-2 variants B. 1.429 and B. 1.351

X Shen, H Tang, R Pajon, G Smith… - … England Journal of …, 2021 - Mass Medical Soc
X Shen, H Tang, R Pajon, G Smith, GM Glenn, W Shi, B Korber, DC Montefiori
New England Journal of Medicine, 2021Mass Medical Soc
Cross-Reactive Neutralization of SARS-CoV-2 Variants An analysis of cross-reactive viral
binding and neutralization of emerging SARS-CoV-2 variants, modeled with the use of
pseudoviruses, suggests that the mRNA-1273 and NVX-CoV2373 vaccines are effective at
neutralizing the B. 1.429 variant and are less effective at neutralizing the B. 1.351 variant.
Cross-Reactive Neutralization of SARS-CoV-2 Variants
An analysis of cross-reactive viral binding and neutralization of emerging SARS-CoV-2 variants, modeled with the use of pseudoviruses, suggests that the mRNA-1273 and NVX-CoV2373 vaccines are effective at neutralizing the B.1.429 variant and are less effective at neutralizing the B.1.351 variant.
The New England Journal Of Medicine